GroPep infertility data presented at US meeting

GroPep's program to develop a treatment for infertility reached another milestone with the release of key data at the 25th Anniversary Meeting of the American Society for Reproductive Immunology in the US. The data will be presented by a leading international researcher in infertility.

More than 50% of recurrent miscarriages have no apparent explanation* and the market for a drug to correct this is potentially worth up to US$750 million annually.

Following the success of pre-clinical studies performed at McMaster University in Canada, the GroPep drug is on track to be tested in Phase I trials during 2006.

A leading international infertility researcher, Professor David Clark, will present key pre-clinical data on GroPep's infertility drug, PV903, at the 25th Anniversary Meeting of the American Society for Reproductive Immunology in Providence, Rhode Island, 16-18 June 2005.

Professor Clark's research found that administration of a single dose of the GroPep drug PV903 halved the miscarriage rate in a strain of female mice susceptible to the immune rejection of the foetus (a suspected major cause of recurrent miscarriage in women).

Scientists believe that women who suffer from repeated miscarriage have an immune system that attacks the embryo as "foreign" in the same way it would a virus or bacteria. The GroPep drug contains an active ingredient found in semen (called a "cytokine") that is thought to instruct the mother's immune system to "tolerate" the foetus.

Professor Clark, who was President of the American Society for Reproductive Immunology between 1996 and 1998, said: "This is the first time a cytokine has been shown to positively affect reproductive outcome in an animal model of reproductive failure that shares many pathological features with recurrent miscarriage in humans. Clinical trials in women with a history of recurrent miscarriage are warranted."

He further noted that: "Past advances in endo

Contact: Mr Tony Mitchell
Research Australia

Page: 1 2

Related biology news :

1. GroPep announces US FDA approval of biopharmaceutical that uses its cell culture product
2. GroPep announces Japanese approval of biopharmaceutical that uses its cell culture products
3. Male or female factor infertility -- men suffer just the same
4. Risk-taking in infertility treatment correlates with womens negative moods
5. New research holds promise for protecting cancer patients against infertility
6. Stressed-out African naked mole-rats may provide clues about human infertility
7. Key to male infertility
8. Researchers find gene mutation that causes infertility in male mice
9. Treating male infertility with stem cells
10. Eating ice cream may help women to conceive, but low-fat dairy foods may increase infertility risk
11. World-first stem cell research could aid male infertility

Post Your Comments:

(Date:8/21/2020)... ... August 19, 2020 , ... The 19th Annual ... science, data science, informatics and IT leaders goes VIRTUAL and announces its updated ... and change, Bio-IT takes the leadership role of keeping our life science community ...
(Date:8/12/2020)... ... August 12, 2020 , ... Mosio recently ... ideal for public health agencies of all sizes. With a focus on tracking ... individuals find appropriate health care, Mosio helps public health departments automate communications and ...
(Date:8/5/2020)... Fla. (PRWEB) , ... August 05, 2020 , ... Regenative ... cover two new innovations, CoreText™ and ProText™, making them the first Wharton’s jelly allografts ... defect using a syringe. The company’s solutions are the first Wharton’s jelly allograft product ...
Breaking Biology News(10 mins):
(Date:8/12/2020)... , ... August 11, 2020 ... ... biopharmaceutical cold chain validation engineering firm, is making available for free its ... need to incorporate concurrent transport simulation testing into today’s biologics licensing application ...
(Date:7/31/2020)... SCOTTSDALE, Ariz. (PRWEB) , ... July 29, 2020 , ... ... cell joint injections for only $3950. With 50 million stem cells total, patients may ... well stem cell therapy works for arthritic joints (BMC Musculoskelet Disord. 2016). At R3 ...
(Date:7/31/2020)... ... ... eSource has long been touted as the solution to high data management and monitoring ... did not take off as quickly as people initially expected, and where eSource is ... data electronically for clinical trials and then repurposing it for downstream analysis, at a ...
(Date:7/18/2020)... ... ... “We are thrilled to deliver this new technology to the industry” said Matt ... the market and we were pleased that the IFT jury recognized that.” reFRESH™ couples ... a natural way to extend the shelf life and improve the safety of perishable ...
Breaking Biology Technology:
Cached News: